1. Home
  2. GH vs WHR Comparison

GH vs WHR Comparison

Compare GH & WHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GH
  • WHR
  • Stock Information
  • Founded
  • GH 2011
  • WHR 1911
  • Country
  • GH United States
  • WHR United States
  • Employees
  • GH N/A
  • WHR N/A
  • Industry
  • GH Medical Specialities
  • WHR Consumer Electronics/Appliances
  • Sector
  • GH Health Care
  • WHR Consumer Discretionary
  • Exchange
  • GH Nasdaq
  • WHR Nasdaq
  • Market Cap
  • GH 5.5B
  • WHR 4.6B
  • IPO Year
  • GH 2018
  • WHR N/A
  • Fundamental
  • Price
  • GH $40.62
  • WHR $78.16
  • Analyst Decision
  • GH Strong Buy
  • WHR Hold
  • Analyst Count
  • GH 21
  • WHR 4
  • Target Price
  • GH $52.81
  • WHR $101.00
  • AVG Volume (30 Days)
  • GH 2.3M
  • WHR 1.1M
  • Earning Date
  • GH 04-30-2025
  • WHR 07-23-2025
  • Dividend Yield
  • GH N/A
  • WHR 8.96%
  • EPS Growth
  • GH N/A
  • WHR N/A
  • EPS
  • GH N/A
  • WHR 0.13
  • Revenue
  • GH $773,996,000.00
  • WHR $15,738,000,000.00
  • Revenue This Year
  • GH $23.05
  • WHR N/A
  • Revenue Next Year
  • GH $21.40
  • WHR $1.26
  • P/E Ratio
  • GH N/A
  • WHR $620.37
  • Revenue Growth
  • GH 28.20
  • WHR N/A
  • 52 Week Low
  • GH $20.14
  • WHR $73.72
  • 52 Week High
  • GH $52.92
  • WHR $135.49
  • Technical
  • Relative Strength Index (RSI)
  • GH 48.45
  • WHR 43.44
  • Support Level
  • GH $37.73
  • WHR $76.07
  • Resistance Level
  • GH $39.63
  • WHR $80.61
  • Average True Range (ATR)
  • GH 1.60
  • WHR 2.33
  • MACD
  • GH -0.01
  • WHR -0.04
  • Stochastic Oscillator
  • GH 60.00
  • WHR 18.64

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About WHR Whirlpool Corporation

Whirlpool Corp is a manufacturer and marketer of home appliances and related products. Its reportable segments consist of five operating segments, which consist of Domestic Appliances (MDA) North America; MDA Europe, MDA Latin America; MDA Asia; and Small Domestic Appliances (SDA). Product categories include refrigeration, laundry, cooking, and dishwashing. The company has also a portfolio of small domestic appliances, including the KitchenAid stand mixer. The company's international brands include Whirlpool, KitchenAid, Maytag, Consul, and Brastemp, among others.

Share on Social Networks: